These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 19067038

  • 21. Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinoma.
    Ren Y, Su C, Zhou Y, Zhao X, Yang CL, Liu YY.
    World J Gastroenterol; 2014 Dec 21; 20(47):17970-5. PubMed ID: 25548496
    [Abstract] [Full Text] [Related]

  • 22. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy.
    Chen G, Wang Z, Liu XY, Liu FY.
    World J Surg; 2007 May 21; 31(5):1107-14. PubMed ID: 17426905
    [Abstract] [Full Text] [Related]

  • 23. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.
    Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, Nagasue N.
    Am J Surg; 2005 Jan 21; 189(1):98-109. PubMed ID: 15701501
    [Abstract] [Full Text] [Related]

  • 24. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
    Wang Y, Wang L, Yang Q, Li J, He M, Yao J, Qi Z, Li B, Qiao X.
    Zhonghua Zhong Liu Za Zhi; 2016 Jan 21; 38(1):48-54. PubMed ID: 26796807
    [Abstract] [Full Text] [Related]

  • 25. Treatment outcome and prognosis of patients with lymph node recurrence of thoracic esophageal squamous cell carcinoma after curative resection.
    Kosuga T, Shiozaki A, Fujiwara H, Ichikawa D, Okamoto K, Komatsu S, Otsuji E.
    World J Surg; 2011 Apr 21; 35(4):798-804. PubMed ID: 21312037
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A strategy for supraclavicular lymph node dissection using recurrent laryngeal nerve lymph node status in thoracic esophageal squamous cell carcinoma.
    Taniyama Y, Nakamura T, Mitamura A, Teshima J, Katsura K, Abe S, Nakano T, Kamei T, Miyata G, Ouchi N.
    Ann Thorac Surg; 2013 Jun 21; 95(6):1930-7. PubMed ID: 23642437
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Analysis of lymph node metastasis in the thoracic esophageal squamous cell carcinoma].
    Zhu ZJ, Zhao YF, Hu Y, Chen LQ, Liu LX, Wu Z, Kou YL, Wang Y.
    Zhonghua Zhong Liu Za Zhi; 2008 Feb 21; 30(2):138-40. PubMed ID: 18646699
    [Abstract] [Full Text] [Related]

  • 31. [Esophageal adenocarcinoma: the clinicopathologic features, patterns of lymph node metastasis and its influencing factors].
    Wang J, Li N, Wang XF, Jing SW, Yang CR, Wang Y, Cao F, Jiao WP, Wu YJ, Guo Y.
    Zhonghua Zhong Liu Za Zhi; 2016 Jul 21; 38(7):515-20. PubMed ID: 27531265
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Clinical implications of the new TNM staging system for thoracic esophageal squamous cell carcinoma].
    Fang WT, Feng J, Mao T, Fu SJ, Chen WH.
    Zhonghua Zhong Liu Za Zhi; 2011 Sep 21; 33(9):687-91. PubMed ID: 22340051
    [Abstract] [Full Text] [Related]

  • 34. Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma.
    Chen J, Pan J, Zheng X, Zhu K, Li J, Chen M, Wang J, Liao Z.
    Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):475-82. PubMed ID: 20934269
    [Abstract] [Full Text] [Related]

  • 35. [Analysis of early lymph node metastasis pattern and prognosis in thoracic esophageal squamous cell carcinoma].
    Ma Z, Tang P, Zhang H, Chen C, Yu Z.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Sep 01; 17(9):884-7. PubMed ID: 25273656
    [Abstract] [Full Text] [Related]

  • 36. [Analysis of lymph node metastases in early esophageal carcinoma and treatment regimens].
    Li L, Liu SY, Zhu KS, Chen JQ, Ying MG.
    Zhonghua Zhong Liu Za Zhi; 2009 Mar 01; 31(3):226-9. PubMed ID: 19615267
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. BRF2 as a promising indicator for radical lymph-node dissection surgery in patients with cN0 squamous cell carcinoma of the middle thoracic esophagus.
    Tian Y, Wang C, Lu M.
    Surg Today; 2019 Feb 01; 49(2):158-169. PubMed ID: 30182305
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Status of involved lymph nodes and direction of metastatic lymphatic flow between submucosal and t2-4 thoracic squamous cell esophageal cancers.
    Motoyama S, Maruyama K, Sato Y, Usami S, Nakatsu T, Saito H, Minamiya Y, Ogawa J.
    World J Surg; 2009 Mar 01; 33(3):512-7. PubMed ID: 19009319
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.